Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.
Tzialla C, Berardi A, Farina C, Clerici P, Borghesi A, Viora E, Scollo P, Stronati M; Task Force for group B streptococcal infections for the Italian Society of Neonatology; Italian Society of Obstetricians and Gynecologists; Italian Association of Clinical Microbiologists. Tzialla C, et al. Among authors: scollo p. Ital J Pediatr. 2017 Nov 2;43(1):98. doi: 10.1186/s13052-017-0409-1. Ital J Pediatr. 2017. PMID: 29096709 Free PMC article.
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.
Bogani G, Apolone G, Ditto A, Scambia G, Panici PB, Angioli R, Pignata S, Greggi S, Scollo P, Delia M, Franchi M, Martinelli F, Signorelli M, Lopez S, Di Donato V, Valabrega G, Ferrandina G, Palaia I, Bergamini A, Bocciolone L, Savarese A, Ghezzi F, Casarin J, Pinelli C, Trojano V, Chiantera V, Giorda G, Sopracordevole F, Malzoni M, Salerno G, Sartori E, Testa A, Zannoni G, Zullo F, Vizza E, Trojano G, Chiantera A, Raspagliesi F. Bogani G, et al. Among authors: scollo p. J Gynecol Oncol. 2020 Nov;31(6):e92. doi: 10.3802/jgo.2020.31.e92. J Gynecol Oncol. 2020. PMID: 33078597 Free PMC article.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M, Canevari S, Califano D, Losito S, Maio MD, Raspagliesi F, Carcangiu ML, Toffoli G, Cecchin E, Sorio R, Canzonieri V, Russo D, Scognamiglio G, Chiappetta G, Baldassarre G, Lorusso D, Scambia G, Zannoni GF, Savarese A, Carosi M, Scollo P, Breda E, Murgia V, Perrone F, Pignata S, De Cecco L, Mezzanzanica D; Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Bagnoli M, et al. Among authors: scollo p. Lancet Oncol. 2016 Aug;17(8):1137-1146. doi: 10.1016/S1470-2045(16)30108-5. Epub 2016 Jul 9. Lancet Oncol. 2016. PMID: 27402147 Free article.
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
Perrone F, Baldassarre G, Indraccolo S, Signoriello S, Chiappetta G, Esposito F, Ferrandina G, Franco R, Mezzanzanica D, Sonego M, Zulato E, Zannoni GF, Canzonieri V, Scambia G, Sorio R, Savarese A, Breda E, Scollo P, Ferro A, Tamberi S, Febbraro A, Natale D, Di Maio M, Califano D, Scognamiglio G, Lorusso D, Canevari S, Losito S, Gallo C, Pignata S. Perrone F, et al. Among authors: scollo p. Oncotarget. 2016 Nov 8;7(45):72654-72661. doi: 10.18632/oncotarget.12056. Oncotarget. 2016. PMID: 27655643 Free PMC article. Clinical Trial.
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).
Marchetti C, Ferrandina G, Cormio G, Gambino A, Cecere S, Lorusso D, De Giorgi U, Bogliolo S, Fagotti A, Mammoliti S, Narducci F, Bergamini A, Scollo P, Biglia N, Breda E, Tamberi S, Marinaccio M, Angioli R, Salerno L, Eusebi MC, Loizzi V, Scambia G, Panici PB. Marchetti C, et al. Among authors: scollo p. Gynecol Oncol. 2016 Dec;143(3):532-538. doi: 10.1016/j.ygyno.2016.09.025. Epub 2016 Oct 5. Gynecol Oncol. 2016. PMID: 27717490
1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.
Cavaliere D, Cirocchi R, Coccolini F, Fagotti A, Fambrini M, Federici O, Lorusso D, Vaira M, Ceresoli M, Delrio P, Garofalo A, Pignata S, Scollo P, Trojano V, Amadori A, Ansaloni L, Cariti G, De Cian F, De Iaco P, De Simone M, Deraco M, Donini A, Fiorentini G, Frigerio L, Greggi S, Macrì A, Pasqual EM, Roviello F, Sammartino P, Sassaroli C, Scambia G, Staudacher C, Vici P, Vizza E, Valle M; Italian Society of Surgical Oncology (SICO); Italian Society of Obstetrics and Gynaecology (SIGO); Italian Association of Hospital Obstetricians and Gynaecologists (AOGOI); Italian Association of Medical Oncology (AIOM). Cavaliere D, et al. Among authors: scollo p. Tumori. 2017 Nov 23;103(6):525-536. doi: 10.5301/tj.5000623. Epub 2017 Apr 20. Tumori. 2017. PMID: 28430350
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Cecere SC, Giannone G, Salutari V, Arenare L, Lorusso D, Ronzino G, Lauria R, Cormio G, Carella C, Scollo P, Ghizzoni V, Raspagliesi F, Di Napoli M, Mazzoni E, Marchetti C, Bergamini A, Orditura M, Valabrega G, Scambia G, Maltese G, De Matteis E, Cardalesi C, Loizzi V, Boccia S, Naglieri E, Scandurra G, Pignata S. Cecere SC, et al. Among authors: scollo p. Gynecol Oncol. 2020 Jan;156(1):38-44. doi: 10.1016/j.ygyno.2019.10.023. Epub 2019 Nov 4. Gynecol Oncol. 2020. PMID: 31699415 Free article.
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Brewer M, Angioli R, Scambia G, Lorusso D, Terranova C, Panici PB, Raspagliesi F, Scollo P, Plotti F, Ferrandina G, Salutari V, Ricci C, Braly P, Holloway R, Method M, Madiyalakan M, Bayever E, Nicodemus C. Brewer M, et al. Among authors: scollo p. Gynecol Oncol. 2020 Mar;156(3):523-529. doi: 10.1016/j.ygyno.2019.12.024. Epub 2020 Jan 6. Gynecol Oncol. 2020. PMID: 31916979 Clinical Trial.
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group.
Ditto A, Casarin I, Pinelli C, Perrone AM, Scollo P, Martinelli F, Bogani G, Leone Roberti Maggiore U, Signorelli M, Chiappa V, Giorda G, Scibilia G, De Iaco P, Evangelista M, Ghezzi F, Paolini B, Lo Vullo S, Mariani L, Montone R, Raspagliesi F. Ditto A, et al. Among authors: scollo p. Eur J Cancer. 2020 Nov;140:1-10. doi: 10.1016/j.ejca.2020.08.030. Epub 2020 Oct 5. Eur J Cancer. 2020. PMID: 33027722 Clinical Trial.
116 results